Streetbeat News

Products Services

NKTX

Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company, released its financial results for Q3 2024. The company is focused on developing engineered natural killer cell therapies.

Portfolio Pulse from

November 07, 2024 | 9:15 pm

ELVN

Enliven Therapeutics, a clinical-stage biopharmaceutical company, will participate in a fireside chat at the Jefferies London Healthcare Conference on November 19, 2024.

Portfolio Pulse from

November 07, 2024 | 9:15 pm

ELF

e.l.f. Beauty's stock experienced a significant rebound as the company continues to capture a larger share of the cosmetics market.

Portfolio Pulse from

November 07, 2024 | 9:15 pm

LPTH

LightPath Technologies announced its fiscal 2025 first quarter financial results, highlighting its role as a provider of optics and imaging systems for defense and commercial applications.

Portfolio Pulse from

November 07, 2024 | 9:15 pm

NXTC

NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company, has released its third-quarter 2024 financial results and provided a business update. The company is focused on developing novel cancer therapies.

Portfolio Pulse from

November 07, 2024 | 9:15 pm

ATHA

Athira Pharma has released its Q3 2024 financial results and provided updates on its pipeline. The company expects to complete a Phase 1 clinical study of ATH-1105 by the end of the year and plans to start dosing ALS patients in 2025.

Portfolio Pulse from

November 07, 2024 | 9:15 pm

PSTX

Poseida Therapeutics reported strong financial results and collaboration momentum for Q3 2024, with significant partnerships with Roche and Astellas. The company achieved cash flow positivity and presented promising Phase 1 results for its P-BCMA-ALLO1 program.

Portfolio Pulse from

November 07, 2024 | 9:15 pm

BBI

Boundless Bio has reported its third quarter 2024 financial results and business highlights. The company is progressing with enrollment in its BBI-355 POTENTIATE and BBI-825 STARMAP clinical trials, with initial proof-of-concept data expected in the second half of 2025.

Portfolio Pulse from

November 07, 2024 | 9:15 pm

LTRX

Lantronix Inc. has announced a definitive agreement to acquire the enterprise IoT business of NetComm from DZS, Inc. for $6.5 million. This acquisition aims to enhance Lantronix's position in the IoT market, particularly in the Enterprise and Smart City sectors, and expand its 5G capabilities.

Portfolio Pulse from

November 07, 2024 | 9:15 pm

REZI

Resideo Technologies, Inc. reported strong financial results for Q3 2024, with an 18% year-over-year net revenue growth and a gross margin improvement in its Products and Solutions segment. The company also highlighted strong demand for its Honeywell Home Focus Pro™ thermostat portfolio.

Portfolio Pulse from

November 07, 2024 | 9:15 pm